FDA accepts pembrolizumab as single agent for treatment of advanced endometrial cancer
August 16th 2021The FDA has accepted a new supplemental biologics license application for pembrolizumab, an anti-PD-1 therapy, as a single agent for the treatment of patients with advanced endometrial carcinoma that is microsatellite instability-high or mismatch repair deficient, who have diseased progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.
Study finds risk of pregnancy low prior to IUD placement following recent unprotected sex
August 12th 2021The findings of a secondary analysis from a randomized trial of intrauterine devices (IUDs) for emergency contraception should bolster confidence about the low pregnancy risk when providers insert an IUD following a recent episode of unprotected intercourse.
Emergency department visits increase for fibroids, while hospital admissions decrease
August 12th 2021Emergency department (ED) visits in women affected by leiomyomas, or uterine fibroids (UFs), are increasing, but hospital admissions for this patient population are decreasing, according to a study published in the journal Obstetrics & Gynecology.
Looking back on a disturbing case of health care fraud
August 5th 2021In last month’s Legally Speaking, we published “Health care fraud exposed” by James M. Shwayder, MD, JD. It is disturbing in its details but exposes fraud and medical malpractice that went on for years. The ob-gyn at the center of it, Javaid Perwaiz, was recently sentenced to 59 years in prison.
Breastfeeding and alcohol: Do they mix?
August 5th 2021Even with these recommendations, women commonly ask questions about alcohol consumption and breastfeeding such as “Should I pump and dump if I have a glass of wine?” and “Do I just wait until it has passed through my system?” This month, experts Susan Crowe, MD, and Tricia Wright, MD, MS, provide the needed insight—with as much data as are available on this topic.